SBIR-STTR Award

Miniature EEG Telemetry Device for Translational Epilepsy Research
Award last edited on: 6/12/17

Sponsored Program
SBIR
Awarding Agency
NIH : NINDS
Total Award Amount
$4,857,443
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Mark J Lehmkuhle

Company Information

Epitel Inc

630 South Stringfellow Court Unit B
Salt Lake City, UT 84111
   (801) 497-6297
   info@epitelinc.com
   www.epitelinc.com
Location: Single
Congr. District: 02
County: Salt Lake

Phase I

Contract Number: 1R43NS064661-01A2
Start Date: 9/22/09    Completed: 6/30/11
Phase I year
2009
Phase I Amount
$349,978
Long-term continuous recording of electrical events from animal models of neurological disease is a critical component of translational research aimed at developing new therapies for debilitating disorders, such as epilepsy. Recordings of the electroencephalogram (EEG) can be obtained for weeks or months at a time from adult rats with either tethered (i.e., "wired") or telemetric (i.e., "wireless") recording systems; however, both of these systems have problems. The proposed studies will further develop and validate a miniature telemetry system (i.e., the EpiTel device) that will be optimized to record continuous (i.e., virtually uninterrupted) electrographic activity from rodent models of neurological disorders, such as intractable epilepsy. The fundamental principle of the EpiTel device is that a small self-contained telemetry unit with easily replaceable and inexpensive batteries is secured to the rodent's head. If this unit is damaged, it can be readily replaced. A provisional patent for the EpiTel device has been submitted. The proposed experiments will use animal models of acquired epilepsy, and will aim to obtain stable long-term continuous recordings from adult rats and mice with convulsive seizures. The long-term goal is for researchers to be able to use the EpiTel device in translational research to develop new therapies for different types of animal models of acquired epilepsy. We have preliminary "proof-of-principle" data, but aim to test the newly-developed EpiTel device in rat and mouse models of epilepsy. The goal in Phase I is to show that it is feasible to obtain long-term continuous recordings (i.e., for many months at a time). Ultimately, the EpiTel device could also be adapted to immature rats in order to allow studies of pediatric epilepsy. These experiments will allow better validation of animal models of epilepsy and other neurological disorders. The ability to obtain long-term continuous recordings should facilitate the development of new therapies to suppress epileptic seizures and potentially to block the development of chronic epilepsy after brain injury.

Public Health Relevance:
This grant proposal aims to develop and validate a new miniature telemetry system for rats and mice that should facilitate translational research on animal models of epilepsy.

Public Health Relevance Statement:
This grant proposal aims to develop and validate a new miniature telemetry system for rats and mice that should facilitate translational research on animal models of epilepsy.

NIH Spending Category:
Bioengineering; Brain Disorders; Epilepsy; Neurodegenerative; Neurosciences

Project Terms:
2(3H)-Furanone, 3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-, (3S-cis)-; 21+ years old; Acquired brain injury; Adult; Animal Model; Animal Models and Related Studies; Animals; Apoplexy; Applications Grants; Bone structure of cranium; Brain Injuries; Cerebral Stroke; Cerebrovascular Apoplexy; Cerebrovascular Stroke; Cerebrovascular accident; Childhood; Chronic; Common Rat Strains; Cranium; Data; Development; Devices; Disease; Disorder; Electroencephalogram; Epilepsy; Epileptic Seizures; Epileptics; Event; Goals; Grant Proposals; Grants, Applications; Head; High Throughput Assay; Human; Human, Adult; Human, General; In Situ; Intractable Epilepsy; Investigators; Laboratories; Legal patent; Mammals, Mice; Mammals, Rats; Mammals, Rodents; Man (Taxonomy); Man, Modern; Marketing; Mice; Motor Seizures; Murine; Mus; Nervous System Diseases; Neurologic Disorders; Neurological Disorders; Patents; Phase; Pilocarpine; Rat; Rattus; Reoperation; Repeat Surgery; Research; Research Personnel; Researchers; Rodent; Rodent Model; Rodentia; Rodentias; Secure; Seizure Disorder; Seizures; Seizures, Convulsive; Seizures, Motor; Services; Skull; Stroke; Surgical Revision; System; System, LOINC Axis 4; TXT; Telemetries; Telemetry; Testing; Text; Time; Translational Research; Translational Research Enterprise; Translational Science; Trauma, Brain; Traumatic Brain Injury; Traumatic encephalopathy; Validation; Vascular Accident, Brain; Wireless Technology; adult human (21+); brain attack; brain damage; brain lesion (from injury); cerebral vascular accident; cranium; design; designing; disease/disorder; epilepsia; epileptiform; epileptogenic; experiment; experimental research; experimental study; high throughput screening; model organism; mouse model; nervous system disorder; neurological disease; pediatric; public health relevance; research study; sleep abnormalities; stroke; translation research enterprise; traumatic brain damage; wireless

Phase II

Contract Number: 5R43NS064661-02
Start Date: 9/22/09    Completed: 6/30/11
Phase II year
2010
(last award dollars: 2016)
Phase II Amount
$4,507,465

Long-term continuous recording of electrical events from animal models of neurological disease is a critical component of translational research aimed at developing new therapies for debilitating disorders, such as epilepsy. Recordings of the electroencephalogram (EEG) can be obtained for weeks or months at a time from adult rats with either tethered (i.e., "wired") or telemetric (i.e., "wireless") recording systems; however, both of these systems have problems. The proposed studies will further develop and validate a miniature telemetry system (i.e., the EpiTel device) that will be optimized to record continuous (i.e., virtually uninterrupted) electrographic activity from rodent models of neurological disorders, such as intractable epilepsy. The fundamental principle of the EpiTel device is that a small self-contained telemetry unit with easily replaceable and inexpensive batteries is secured to the rodent's head. If this unit is damaged, it can be readily replaced. A provisional patent for the EpiTel device has been submitted. The proposed experiments will use animal models of acquired epilepsy, and will aim to obtain stable long-term continuous recordings from adult rats and mice with convulsive seizures. The long-term goal is for researchers to be able to use the EpiTel device in translational research to develop new therapies for different types of animal models of acquired epilepsy. We have preliminary "proof-of-principle" data, but aim to test the newly-developed EpiTel device in rat and mouse models of epilepsy. The goal in Phase I is to show that it is feasible to obtain long-term continuous recordings (i.e., for many months at a time). Ultimately, the EpiTel device could also be adapted to immature rats in order to allow studies of pediatric epilepsy. These experiments will allow better validation of animal models of epilepsy and other neurological disorders. The ability to obtain long-term continuous recordings should facilitate the development of new therapies to suppress epileptic seizures and potentially to block the development of chronic epilepsy after brain injury.

Public Health Relevance:
This grant proposal aims to develop and validate a new miniature telemetry system for rats and mice that should facilitate translational research on animal models of epilepsy.

Thesaurus Terms:
2(3h)-Furanone, 3-Ethyldihydro-4-((1-Methyl-1h-Imidazol-5-Yl)Methyl)-, (3s-Cis)-; 21+ Years Old; Acquired Brain Injury; Adult; Animal Model; Animal Models And Related Studies; Animals; Apoplexy; Applications Grants; Bone Structure Of Cranium; Brain Injuries; Cerebral Stroke; Cerebrovascular Apoplexy; Cerebrovascular Stroke; Cerebrovascular Accident; Childhood; Chronic; Common Rat Strains; Cranium; Data; Development; Devices; Disease; Disorder; Electroencephalogram; Epilepsy; Epileptic Seizures; Epileptics; Event; Goals; Grant Proposals; Grants, Applications; Head; High Throughput Assay; Human; Human, Adult; Human, General; In Situ; Intractable Epilepsy; Investigators; Laboratories; Legal Patent; Mammals, Mice; Mammals, Rats; Mammals, Rodents; Man (Taxonomy); Man, Modern; Marketing; Mice; Motor Seizures; Murine; Mus; Nervous System Diseases; Neurologic Disorders; Neurological Disorders; Patents; Phase; Pilocarpine; Rat; Rattus; Reoperation; Repeat Surgery; Research; Research Personnel; Researchers; Rodent; Rodent Model; Rodentia; Rodentias; Secure; Seizure Disorder; Seizures; Seizures, Convulsive; Seizures, Motor; Services; Skull; Stroke; Surgical Revision; System; System, Loinc Axis 4; Txt; Telemetries; Telemetry; Testing; Text; Time; Translational Research; Translational Research Enterprise; Translational Science; Trauma, Brain; Traumatic Brain Injury; Traumatic Encephalopathy; Validation; Vascular Accident, Brain; Wireless Technology; Adult Human (21+); Brain Attack; Brain Damage; Brain Lesion (From Injury); Cerebral Vascular Accident; Cranium; Design; Designing; Disease/Disorder; Epilepsia; Epileptiform; Epileptogenic; Experiment; Experimental Research; Experimental Study; High Throughput Screening; Model Organism; Mouse Model; Nervous System Disorder; Neurological Disease; Pediatric; Public Health Relevance; Research Study; Sleep Abnormalities; Stroke; Translation Research Enterprise; Traumatic Brain Damage; Wireless